{
    "nct_id": "NCT06369610",
    "official_title": "Risk Stratified De-Escalated De-Intensified Treatment for High Risk Prostate Cancer Patients Based on Pathologic Criteria, Genetic Score, and Biologic Imaging",
    "inclusion_criteria": "* Histologically confirmed high risk prostate adenocarcinoma\n* Pathologic stages T1c-T4, N0-Nx-N1, M0-1 as staged by the pathology report (AJCC Criteria 8th Edition [Ed].)\n* One or more high risk features including Gleason 8-10, T3-T4, prostate specific antigen (PSA) â‰¥ 20\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n* Patients must sign institutional review board (IRB) approved study specific informed consent\n* Patients must complete all required pre-entry tests\n* Patients must be at least 18 years old\n* Oligometastatic prostate cancer defined as disease in up to 5 distant or regional areas (group 3 only)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous pelvic radiation\n* Prior androgen suppression therapy for prostate cancer for more than 6 months\n* Active rectal diverticulitis, Crohn's disease affecting the rectum or ulcerative colitis (non-active diverticulitis and Crohn's disease not affecting the rectum are allowed)\n* Prior systemic chemotherapy for prostate cancer\n* History of proximal urethral stricture requiring dilatation\n* Current and continuing anticoagulation with warfarin sodium (Coumadin), heparin, low-molecular weight heparin, clopidogrel bisulfate (Plavix), or equivalent (unless it can be stopped to manage treatment related toxicity, to have a biopsy if needed, or place markers)\n* Major medical, addictive or psychiatric illness which in the investigator's opinion, will prevent the consent process, completion of the treatment and/or interfere with follow-up. (Consent by legal authorized representative is not permitted for this study)\n* Evidence of any other cancer within the past 5 years and < 50% probability of a 5 year survival. (Prior or concurrent diagnosis of basal cell or non-invasive squamous cell cancer of the skin is allowed)\n* History of myocardial infarction or decompensated congestive heart failure (CHF) within the last 6 months",
    "miscellaneous_criteria": ""
}